Olmesartan/Amlodipin/Hct Heumann (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan/Amlodipin/Hct Heumann is used to manage hypertension, a condition characterized by elevated arterial pressure.

• Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk.
• Hypertensive heart disease: improves cardiac workload and prevents disease progression.
• Chronic kidney disease with hypertension: slows renal function decline by controlling blood pressure.

• The combination product contains three agents that act on separate pathways controlling vascular tone and fluid balance. Olmesartan blocks the angiotensin II type‑1 receptor, preventing vasoconstriction. Amlodipine inhibits calcium influx into vascular smooth‑muscle cells, producing arterial dilation. Hydrochlorothiazide reduces sodium and water reabsorption in the distal tubules, decreasing plasma volume. Together they provide additive blood‑pressure‑lowering effects.

Common Side Effects

• Headache: mild to moderate tension‑type headache.
• Peripheral edema: swelling of ankles or feet, especially with amlodipine.
• Dizziness: sensation of light‑headedness, often upon standing.
• Fatigue: general tiredness without specific cause.
• Cough: dry, non‑productive cough, less common than with ACE inhibitors.
• Increased urination: due to the diuretic component.

Serious or Rare Side Effects

• Hyperkalemia: elevated potassium levels that may cause cardiac arrhythmia.
• Acute kidney injury: sudden reduction in renal function.
• Severe hypotension: marked drop in blood pressure leading to fainting.
• Angio‑edema: rapid swelling of face, lips, tongue, or airway.
• Liver enzyme elevation: abnormal liver function tests.
• Blood dyscrasias: rare blood cell abnormalities such as agranulocytosis.

When prescribing Olmesartan/Amlodipin/Hct Heumann, clinicians should consider patient‑specific factors and monitor for adverse reactions.

• Renal impairment: adjust monitoring and avoid in severe cases.
• Electrolyte disturbances: watch for low potassium or sodium levels.
• Hepatic dysfunction: use with caution in patients with liver disease.
• Pregnancy: contraindicated; avoid use during gestation.
• Elderly patients: start at lower dose and monitor for orthostatic hypotension.
• Store at below 25°C: keep in the original packaging, protect from moisture and light.

Olmesartan/Amlodipin/Hct Heumann may interact with several drug classes, requiring careful review of a patient’s medication list.

Major Interactions (Avoid)

• Potassium‑rich supplements or salts: risk of hyper‑kalemia.
• Other renin‑angiotensin system blockers (ACE inhibitors, ARBs): additive hypotensive effect.
• Strong CYP3A4 inhibitors (e.g., itraconazole): increase amlodipine levels.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response.
• Lithium: increased lithium levels and toxicity risk.
• Diuretics other than hydrochlorothiazide: enhanced electrolyte shifts.
• Antidiabetic agents: may require dose adjustment due to blood‑pressure‑related glucose changes.